Navigating the Diagnostic Challenges of Mycoplasma and Legionella Coinfection Through Serological Testing

Sushma Edara1, Sivaprasad Nalluri2

  • 1Internal Medicine, Interfaith Medical Center, New York, USA.

Cureus
|April 22, 2024
PubMed

Insights

Diagnosing community-acquired pneumonia (CAP) is challenging with atypical pathogens. This case highlights the complexity of differentiating coinfection from primary infection in patients with Mycoplasma pneumoniae and Legionella pneumophila.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) diagnosis is complicated by atypical pathogens like Mycoplasma pneumoniae and Legionella pneumophila.
  • Accurate diagnosis is crucial for effective treatment and patient outcomes.

Observation:

  • A 60-year-old male with chronic kidney disease presented with lethargy and reduced oral intake.
  • A positive Legionella urine antigen test was noted, but clinical and radiological findings were inconsistent with Legionella pneumonia.
  • Elevated Mycoplasma pneumoniae IgM antibody titers were detected, adding diagnostic complexity.

Findings:

  • The case illustrates challenges in distinguishing between coinfection and primary infection in CAP.
  • Limitations of serological testing, such as Mycoplasma pneumoniae IgM, are highlighted.
  • Discordance between diagnostic markers (Legionella antigen) and clinical presentation was observed.

Implications:

  • Emphasizes the need for comprehensive diagnostic strategies tailored to individual patient profiles.
  • Underscores the importance of considering multiple atypical pathogens in CAP diagnosis.
  • Suggests a need for critical evaluation of diagnostic test results in the context of the overall clinical picture.